Organization Overview
Historical Acquisition Tree
Alternative names
belinostat (beleodaq) (2014 NDA)
fluorouracil (efudex) (1962)
ibritumomab tiuxetan (zevalin) (2009)
levoleucovorin (fusilev) (2008 NDA)
melphalan (alkeran) (2016)
Key: Spectrum Pharmaceuticals (42) Acquired (1)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (2 trials)
belinostat (beleodaq) (12 trials)
bendamustine (treanda) (3 trials)
bortezomib (velcade) (2 trials)
clofarabine (clolar) (1 trial)
cyanocobalamin (berocca) (8 trials)
cyclosporine (sandimmune) (1 trial)
cytarabine (cytosar-u) (3 trials)
etoposide (vepesid) (2 trials)
fludarabine (fludara) (1 trial)
fludeoxyglucose f-18 (1 trial)
Acute Disease (Phase 1)
Adenocarcinoma (Phase 2)
Amyloidosis (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Transitional Cell (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Exanthema (Phase 1)
Glioblastoma (Phase 2)
Hodgkin Disease (Phase 2)
Hyperkinesis (Phase 3)
Hyperplasia (Phase 2)
Hypertrophy (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, T-Cell (Phase 2)
Lower Urinary Tract Symptoms (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 3)
Melanoma (Phase 2)
Mucositis (Phase 2)
Multiple Myeloma (Phase 2)
Mycoses (Phase 1)
Mycosis Fungoides (Phase 1)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Second Primary (Phase 3)
Neoplasms, Unknown Primary (Phase 2)
Nervous System Diseases (Phase 2)
Neuroblastoma (Phase 2)
Neutropenia (Phase 3)
Ovarian Neoplasms (Phase 1)
Peripheral Nervous System Diseases (Phase 2)
Prostatic Hyperplasia (Phase 3)
Prostatic Neoplasms (Phase 2)
Renal Insufficiency (Phase 1)
Sarcoma (Phase 2)
Sezary Syndrome (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Urinary Bladder Neoplasms (Phase 3)
Uveal Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Wilms Tumor (Phase 2)